http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9412144-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af5978c465dc99fa57524ae217ad798f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef416fe4f66ebb1021cecfb0ba5ae45d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
filingDate 1993-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e3e83e1d220571a0e00dc7c31245a96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f87d3be53c4e8c89909b64ae05f401c
publicationDate 1994-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9412144-A3
titleOfInvention Treatment of infertility and enhancement of fertilization capacity in mammalian males
abstract The present invention relates to the treatment of mammalian male infertility through the administration of fertility enhancing amounts of a fertility enhancing thymosin polypeptide or a fertility enhancing anti-thymosin antibody. In preferred embodiments, treaatment comprises the administration of thymosin α1 or antibodies to thymosin α1 or thymosin β4.
priorityDate 1992-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0056594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4950590-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID781334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130571
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7114
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399438
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID793949
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601108

Total number of triples: 40.